Impact BioMedical Inc. (IBO)
NYSEAMERICAN: IBO · Real-Time Price · USD
1.520
-0.760 (-33.33%)
At close: Mar 28, 2025, 4:00 PM
1.590
+0.070 (4.61%)
After-hours: Mar 28, 2025, 7:59 PM EST
Impact BioMedical Employees
Impact BioMedical had 1 employees as of December 31, 2023. The number of employees decreased by 1 or -50.00% compared to the previous year.
Employees
1
Change (1Y)
-1
Growth (1Y)
-50.00%
Revenue / Employee
n/a
Profits / Employee
-$24,708,000
Market Cap
17.49M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 1 | -1 | -50.00% |
| Dec 31, 2022 | 2 | 0 | - |
| Dec 31, 2021 | 2 | 0 | - |
| Dec 31, 2020 | 2 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
IBO News
- 8 days ago - Impact Biomedical Inc. Announcement Stock Activity/Pricing - GlobeNewsWire
- 2 months ago - Impact BioMedical Inc. to Present at The Microcap Conference - GlobeNewsWire
- 5 months ago - Impact BioMedical Inc. Announces Issuance of Canadian Patent for Linebacker™ Technology Targeting Inflammatory Disease - GlobeNewsWire
- 6 months ago - Impact BioMedical Inc. (NYSE American: IBO) Announces IPO Participation with Strong Support from Partners and Affiliates - GlobeNewsWire
- 6 months ago - Impact BioMedical Inc. (NYSE: IBO) Announces 3F™ US Patent Issue - GlobeNewsWire
- 6 months ago - Impact BioMedical Inc. Announces the Closing of its Initial Public Offering - GlobeNewsWire
- 6 months ago - Impact BioMedical Inc. Announces Pricing of Initial Public Offering - GlobeNewsWire
- 1 year ago - Impact BioMedical IPO Registration Document (S-1) - SEC